Cerebrovascular Reactivity to L-Arginine in Patients with Lacunar Infarctions

Background: It is well known that endothelial dysfunction plays an important role in the pathogenesis of many cardiovascular disorders. The aim of this study was to test the hypothesis that specific, marked endothelial dysfunction of cerebral arteries is present in patients with lacunar cerebral inf...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cerebrovascular diseases (Basel, Switzerland) Switzerland), 2006-01, Vol.21 (3), p.180-186
Hauptverfasser: Pretnar-Oblak, Janja, Zaletel, Marjan, Zvan, Bojana, Sabovic, Miso, Pogacnik, Tomaz
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 186
container_issue 3
container_start_page 180
container_title Cerebrovascular diseases (Basel, Switzerland)
container_volume 21
creator Pretnar-Oblak, Janja
Zaletel, Marjan
Zvan, Bojana
Sabovic, Miso
Pogacnik, Tomaz
description Background: It is well known that endothelial dysfunction plays an important role in the pathogenesis of many cardiovascular disorders. The aim of this study was to test the hypothesis that specific, marked endothelial dysfunction of cerebral arteries is present in patients with lacunar cerebral infarctions. Methods: Cerebrovascular reactivity to L-arginine, which reveals the function of the cerebral endothelium, was investigated in patients with lacunar infarctions (20 patients, 11 male and 9 female, aged 60.9 ± 7.3 years), 21 age- and gender-matched asymptomatic patients with similar cardiovascular risk factors (all patients had arterial hypertension) and 21 age- and gender-matched healthy controls. The mean arterial velocity (v m ) in both middle cerebral arteries was measured by transcranial Doppler sonography during a 15-min baseline period, a 30-min intravenous infusion of L-arginine and a 15-min interval after L-arginine infusion. Arterial blood pressure, heart rate and CO 2 were measured continuously. Results: The measured v m increase during L-arginine infusion in the patients with lacunar infarctions (13.4 ± 9.1%) was significantly lower compared to the healthy controls (20.5 ± 9.9%) but similar to that obtained in the patients with cardiovascular risk factors (11.5 ± 8.9%). Conclusions: Our results showed that cerebrovascular reactivity to L-arginine, which demonstrates cerebral endothelial function, is significantly impaired in patients with cardiovascular risk factors. Importantly, we found that patients with lacunar infarctions do not show any additional impairment of cerebral endothelial function.
doi_str_mv 10.1159/000090530
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_221226448</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>992056661</sourcerecordid><originalsourceid>FETCH-LOGICAL-c361t-29da71f06226dab37fffb180638944bc2f7a262bdf6f91a5d12dd87f93d0c8d03</originalsourceid><addsrcrecordid>eNqF0c1LwzAUAPAgipvTg2dBigfBQzUvbdPkOIYfg4kiei5pk8zMLp1JO9l_b6RjghdzyTv83uN9IHQK-Bog4zc4PI6zBO-hIaQEYp4zuh9iDFmIczxAR94vgqLA4BANgCaMAU-G6HGinCpdsxa-6mrhohclqtasTbuJ2iaaxWM3N9ZYFRkbPYvWKNv66Mu079FMVJ0NGVOrhQs5jfXH6ECL2quT7T9Cb3e3r5OHePZ0P52MZ3GVUGhjwqXIQWNKCJWiTHKtdQkMh654mpYV0bkglJRSU81BZBKIlCzXPJG4YhInI3TZ11255rNTvi2WxleqroVVTecLmlMGBP8PSdhbyikN8OIPXDSds2GIghAIfaYpC-iqR5VrvHdKFytnlsJtCsDFzyWK3SWCPd8W7Mqlkr9yu_oAznrwIdxcuR3o078BP1WK3Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>221226448</pqid></control><display><type>article</type><title>Cerebrovascular Reactivity to L-Arginine in Patients with Lacunar Infarctions</title><source>MEDLINE</source><source>Karger Online</source><creator>Pretnar-Oblak, Janja ; Zaletel, Marjan ; Zvan, Bojana ; Sabovic, Miso ; Pogacnik, Tomaz</creator><creatorcontrib>Pretnar-Oblak, Janja ; Zaletel, Marjan ; Zvan, Bojana ; Sabovic, Miso ; Pogacnik, Tomaz</creatorcontrib><description>Background: It is well known that endothelial dysfunction plays an important role in the pathogenesis of many cardiovascular disorders. The aim of this study was to test the hypothesis that specific, marked endothelial dysfunction of cerebral arteries is present in patients with lacunar cerebral infarctions. Methods: Cerebrovascular reactivity to L-arginine, which reveals the function of the cerebral endothelium, was investigated in patients with lacunar infarctions (20 patients, 11 male and 9 female, aged 60.9 ± 7.3 years), 21 age- and gender-matched asymptomatic patients with similar cardiovascular risk factors (all patients had arterial hypertension) and 21 age- and gender-matched healthy controls. The mean arterial velocity (v m ) in both middle cerebral arteries was measured by transcranial Doppler sonography during a 15-min baseline period, a 30-min intravenous infusion of L-arginine and a 15-min interval after L-arginine infusion. Arterial blood pressure, heart rate and CO 2 were measured continuously. Results: The measured v m increase during L-arginine infusion in the patients with lacunar infarctions (13.4 ± 9.1%) was significantly lower compared to the healthy controls (20.5 ± 9.9%) but similar to that obtained in the patients with cardiovascular risk factors (11.5 ± 8.9%). Conclusions: Our results showed that cerebrovascular reactivity to L-arginine, which demonstrates cerebral endothelial function, is significantly impaired in patients with cardiovascular risk factors. Importantly, we found that patients with lacunar infarctions do not show any additional impairment of cerebral endothelial function.</description><identifier>ISSN: 1015-9770</identifier><identifier>EISSN: 1421-9786</identifier><identifier>DOI: 10.1159/000090530</identifier><identifier>PMID: 16388193</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Aged ; Arginine - administration &amp; dosage ; Arginine - pharmacology ; Blood Flow Velocity ; Blood Pressure - drug effects ; Brain Infarction - physiopathology ; Carbon Dioxide - analysis ; Cardiovascular Diseases - epidemiology ; Cardiovascular Diseases - physiopathology ; Case-Control Studies ; Cerebral Arteries - physiology ; Cerebrovascular Circulation - drug effects ; Endothelial Cells - drug effects ; Endothelial Cells - physiology ; Female ; Heart Rate - drug effects ; Heart Rate - physiology ; Humans ; Infusions, Intravenous ; Male ; Middle Aged ; Nitric Oxide - metabolism ; Nitric Oxide Synthase - physiology ; Original Paper ; Risk Factors ; Time Factors ; Ultrasonography, Doppler, Transcranial</subject><ispartof>Cerebrovascular diseases (Basel, Switzerland), 2006-01, Vol.21 (3), p.180-186</ispartof><rights>2006 S. Karger AG, Basel</rights><rights>Copyright 2006 S. Karger AG, Basel.</rights><rights>Copyright (c) 2006 S. Karger AG, Basel</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c361t-29da71f06226dab37fffb180638944bc2f7a262bdf6f91a5d12dd87f93d0c8d03</citedby><cites>FETCH-LOGICAL-c361t-29da71f06226dab37fffb180638944bc2f7a262bdf6f91a5d12dd87f93d0c8d03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,2429,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16388193$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pretnar-Oblak, Janja</creatorcontrib><creatorcontrib>Zaletel, Marjan</creatorcontrib><creatorcontrib>Zvan, Bojana</creatorcontrib><creatorcontrib>Sabovic, Miso</creatorcontrib><creatorcontrib>Pogacnik, Tomaz</creatorcontrib><title>Cerebrovascular Reactivity to L-Arginine in Patients with Lacunar Infarctions</title><title>Cerebrovascular diseases (Basel, Switzerland)</title><addtitle>Cerebrovasc Dis</addtitle><description>Background: It is well known that endothelial dysfunction plays an important role in the pathogenesis of many cardiovascular disorders. The aim of this study was to test the hypothesis that specific, marked endothelial dysfunction of cerebral arteries is present in patients with lacunar cerebral infarctions. Methods: Cerebrovascular reactivity to L-arginine, which reveals the function of the cerebral endothelium, was investigated in patients with lacunar infarctions (20 patients, 11 male and 9 female, aged 60.9 ± 7.3 years), 21 age- and gender-matched asymptomatic patients with similar cardiovascular risk factors (all patients had arterial hypertension) and 21 age- and gender-matched healthy controls. The mean arterial velocity (v m ) in both middle cerebral arteries was measured by transcranial Doppler sonography during a 15-min baseline period, a 30-min intravenous infusion of L-arginine and a 15-min interval after L-arginine infusion. Arterial blood pressure, heart rate and CO 2 were measured continuously. Results: The measured v m increase during L-arginine infusion in the patients with lacunar infarctions (13.4 ± 9.1%) was significantly lower compared to the healthy controls (20.5 ± 9.9%) but similar to that obtained in the patients with cardiovascular risk factors (11.5 ± 8.9%). Conclusions: Our results showed that cerebrovascular reactivity to L-arginine, which demonstrates cerebral endothelial function, is significantly impaired in patients with cardiovascular risk factors. Importantly, we found that patients with lacunar infarctions do not show any additional impairment of cerebral endothelial function.</description><subject>Aged</subject><subject>Arginine - administration &amp; dosage</subject><subject>Arginine - pharmacology</subject><subject>Blood Flow Velocity</subject><subject>Blood Pressure - drug effects</subject><subject>Brain Infarction - physiopathology</subject><subject>Carbon Dioxide - analysis</subject><subject>Cardiovascular Diseases - epidemiology</subject><subject>Cardiovascular Diseases - physiopathology</subject><subject>Case-Control Studies</subject><subject>Cerebral Arteries - physiology</subject><subject>Cerebrovascular Circulation - drug effects</subject><subject>Endothelial Cells - drug effects</subject><subject>Endothelial Cells - physiology</subject><subject>Female</subject><subject>Heart Rate - drug effects</subject><subject>Heart Rate - physiology</subject><subject>Humans</subject><subject>Infusions, Intravenous</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nitric Oxide - metabolism</subject><subject>Nitric Oxide Synthase - physiology</subject><subject>Original Paper</subject><subject>Risk Factors</subject><subject>Time Factors</subject><subject>Ultrasonography, Doppler, Transcranial</subject><issn>1015-9770</issn><issn>1421-9786</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqF0c1LwzAUAPAgipvTg2dBigfBQzUvbdPkOIYfg4kiei5pk8zMLp1JO9l_b6RjghdzyTv83uN9IHQK-Bog4zc4PI6zBO-hIaQEYp4zuh9iDFmIczxAR94vgqLA4BANgCaMAU-G6HGinCpdsxa-6mrhohclqtasTbuJ2iaaxWM3N9ZYFRkbPYvWKNv66Mu079FMVJ0NGVOrhQs5jfXH6ECL2quT7T9Cb3e3r5OHePZ0P52MZ3GVUGhjwqXIQWNKCJWiTHKtdQkMh654mpYV0bkglJRSU81BZBKIlCzXPJG4YhInI3TZ11255rNTvi2WxleqroVVTecLmlMGBP8PSdhbyikN8OIPXDSds2GIghAIfaYpC-iqR5VrvHdKFytnlsJtCsDFzyWK3SWCPd8W7Mqlkr9yu_oAznrwIdxcuR3o078BP1WK3Q</recordid><startdate>20060101</startdate><enddate>20060101</enddate><creator>Pretnar-Oblak, Janja</creator><creator>Zaletel, Marjan</creator><creator>Zvan, Bojana</creator><creator>Sabovic, Miso</creator><creator>Pogacnik, Tomaz</creator><general>S. Karger AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20060101</creationdate><title>Cerebrovascular Reactivity to L-Arginine in Patients with Lacunar Infarctions</title><author>Pretnar-Oblak, Janja ; Zaletel, Marjan ; Zvan, Bojana ; Sabovic, Miso ; Pogacnik, Tomaz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c361t-29da71f06226dab37fffb180638944bc2f7a262bdf6f91a5d12dd87f93d0c8d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Aged</topic><topic>Arginine - administration &amp; dosage</topic><topic>Arginine - pharmacology</topic><topic>Blood Flow Velocity</topic><topic>Blood Pressure - drug effects</topic><topic>Brain Infarction - physiopathology</topic><topic>Carbon Dioxide - analysis</topic><topic>Cardiovascular Diseases - epidemiology</topic><topic>Cardiovascular Diseases - physiopathology</topic><topic>Case-Control Studies</topic><topic>Cerebral Arteries - physiology</topic><topic>Cerebrovascular Circulation - drug effects</topic><topic>Endothelial Cells - drug effects</topic><topic>Endothelial Cells - physiology</topic><topic>Female</topic><topic>Heart Rate - drug effects</topic><topic>Heart Rate - physiology</topic><topic>Humans</topic><topic>Infusions, Intravenous</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nitric Oxide - metabolism</topic><topic>Nitric Oxide Synthase - physiology</topic><topic>Original Paper</topic><topic>Risk Factors</topic><topic>Time Factors</topic><topic>Ultrasonography, Doppler, Transcranial</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pretnar-Oblak, Janja</creatorcontrib><creatorcontrib>Zaletel, Marjan</creatorcontrib><creatorcontrib>Zvan, Bojana</creatorcontrib><creatorcontrib>Sabovic, Miso</creatorcontrib><creatorcontrib>Pogacnik, Tomaz</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Cerebrovascular diseases (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pretnar-Oblak, Janja</au><au>Zaletel, Marjan</au><au>Zvan, Bojana</au><au>Sabovic, Miso</au><au>Pogacnik, Tomaz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cerebrovascular Reactivity to L-Arginine in Patients with Lacunar Infarctions</atitle><jtitle>Cerebrovascular diseases (Basel, Switzerland)</jtitle><addtitle>Cerebrovasc Dis</addtitle><date>2006-01-01</date><risdate>2006</risdate><volume>21</volume><issue>3</issue><spage>180</spage><epage>186</epage><pages>180-186</pages><issn>1015-9770</issn><eissn>1421-9786</eissn><abstract>Background: It is well known that endothelial dysfunction plays an important role in the pathogenesis of many cardiovascular disorders. The aim of this study was to test the hypothesis that specific, marked endothelial dysfunction of cerebral arteries is present in patients with lacunar cerebral infarctions. Methods: Cerebrovascular reactivity to L-arginine, which reveals the function of the cerebral endothelium, was investigated in patients with lacunar infarctions (20 patients, 11 male and 9 female, aged 60.9 ± 7.3 years), 21 age- and gender-matched asymptomatic patients with similar cardiovascular risk factors (all patients had arterial hypertension) and 21 age- and gender-matched healthy controls. The mean arterial velocity (v m ) in both middle cerebral arteries was measured by transcranial Doppler sonography during a 15-min baseline period, a 30-min intravenous infusion of L-arginine and a 15-min interval after L-arginine infusion. Arterial blood pressure, heart rate and CO 2 were measured continuously. Results: The measured v m increase during L-arginine infusion in the patients with lacunar infarctions (13.4 ± 9.1%) was significantly lower compared to the healthy controls (20.5 ± 9.9%) but similar to that obtained in the patients with cardiovascular risk factors (11.5 ± 8.9%). Conclusions: Our results showed that cerebrovascular reactivity to L-arginine, which demonstrates cerebral endothelial function, is significantly impaired in patients with cardiovascular risk factors. Importantly, we found that patients with lacunar infarctions do not show any additional impairment of cerebral endothelial function.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>16388193</pmid><doi>10.1159/000090530</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1015-9770
ispartof Cerebrovascular diseases (Basel, Switzerland), 2006-01, Vol.21 (3), p.180-186
issn 1015-9770
1421-9786
language eng
recordid cdi_proquest_journals_221226448
source MEDLINE; Karger Online
subjects Aged
Arginine - administration & dosage
Arginine - pharmacology
Blood Flow Velocity
Blood Pressure - drug effects
Brain Infarction - physiopathology
Carbon Dioxide - analysis
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - physiopathology
Case-Control Studies
Cerebral Arteries - physiology
Cerebrovascular Circulation - drug effects
Endothelial Cells - drug effects
Endothelial Cells - physiology
Female
Heart Rate - drug effects
Heart Rate - physiology
Humans
Infusions, Intravenous
Male
Middle Aged
Nitric Oxide - metabolism
Nitric Oxide Synthase - physiology
Original Paper
Risk Factors
Time Factors
Ultrasonography, Doppler, Transcranial
title Cerebrovascular Reactivity to L-Arginine in Patients with Lacunar Infarctions
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T21%3A25%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cerebrovascular%20Reactivity%20to%20L-Arginine%20in%20Patients%20with%20Lacunar%20Infarctions&rft.jtitle=Cerebrovascular%20diseases%20(Basel,%20Switzerland)&rft.au=Pretnar-Oblak,%20Janja&rft.date=2006-01-01&rft.volume=21&rft.issue=3&rft.spage=180&rft.epage=186&rft.pages=180-186&rft.issn=1015-9770&rft.eissn=1421-9786&rft_id=info:doi/10.1159/000090530&rft_dat=%3Cproquest_cross%3E992056661%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=221226448&rft_id=info:pmid/16388193&rfr_iscdi=true